Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
To investigate the extent to which dermatologists are involved in innovative dermatology start-up companies, we analyzed the Pitchbook database which covers private capital markets. From January 1, 2010 to June 23, 2021, there were 105 dermatology companies, of which six (5.7%) had a dermatologist chief executive officer (CEO), 16 (15.2%) had a dermatologist founder, and 19 (18.1%) had a dermatologist advisor or board member. There were 98 dermatologists with leadership positions, including six (6.1%) CEOs, 21 (21.4%) founders, 11 (11.2%) chief medical officers (CMOs), and 60 (61.2%) advisors. Our findings highlight the underrepresentation of dermatologists in start-up ventures relating to dermatology.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5070/D328357781 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Private Equity Acquisitions in Oncology: Impact on Market Share and Prices.
Int J Radiat Oncol Biol Phys
August 2025
Brown University, Providence, RI.
Purpose: Private equity (PE) acquisitions of physician practices have seen a significant increase in recent years. The surge in PE acquisitions raises concerns about market consolidation, affordability, and quality of care, particularly for disadvantaged patients. The Purpose of this study is to examines the trend of PE acquisitions in oncology from 2013 to 2022, quantify market shares, analyze changes in price and spending with particular focus on radiation oncology, and describe the influence on sociodemographic disparities in health outcomes.
View Article and Find Full Text PDFTop-funded digital health companies offering lifestyle interventions for dementia prevention: Company overview and evidence analysis.
PLoS One
May 2025
School of Medicine, University of St. Gallen, St. Gallen, Switzerland.
Background And Objective: Dementia prevention has been recognized as a top priority by public health authorities due to the lack of a reversible cure. In this regard, digital dementia-preventive lifestyle services (DDLS) emerge as potentially pivotal services, aiming to address modifiable risk factors on a large scale. This study aims to identify the top-funded companies offering DDLS and evaluate their clinical evidence to gain insights into the international service landscape.
View Article and Find Full Text PDFPrivate Equity Investment in Plastic Surgery Clinics: A Scoping Review.
Plast Reconstr Surg
April 2025
Division of Plastic and Maxillofacial Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York, New York.
Background: Plastic surgery is emerging as a prime target for Private Equity (PE) investments driven by its increasing demand, scalability, and opportunities for insurance-independent revenue streams. This review synthesizes current literature to evaluate the effects of PE investments on plastic surgery practices.
Methods: Following PRISMA-ScR guidelines, a search was conducted across PubMed, Cochrane Library, and Web of Science databases in November 2024.
Venture Capital Investments in Gastroenterology from 2012 to 2022: A Window into the Future of Gastroenterology.
Dig Dis Sci
August 2025
NYU Langone Health, New York, NY, USA.
Background: Innovation in gastroenterology (GI) is experiencing several favorable tailwinds. Despite the increasing amount of capital invested in the technology and pharmaceutical sectors of GI, trends in venture capital (VC) funding for this field remain understudied. This is the first analysis of VC investment in GI.
View Article and Find Full Text PDFObjective: Investigate how private equity (PE) acquisitions shape the otolaryngology workforce.
Study Design: Cross-sectional.
Setting: Private outpatient clinics.